Compared with normal samples, circ-MYBL2 was significantly reduced in MM tissue and serum samples, and low circ-MYBL2 level was strongly linked to unfavorable outcomes and advanced clinical staging. The gene discussed is MYBL2; the disease is Miyoshi myopathy.